A. Benussi, V. Dell’Era, M.S. Cotelli, M. Turla, C. Casali, A. Padovani, B. Borroni, Brain Stimulation, Available online 3 November 2016, ISSN 1935-861X, doi:10.1016/j.brs.2016.11.001.
We performed a double-blind, randomized, sham controlled trial with cerebellar tDCS (5 days/week for 2 weeks) in twenty patients with ataxia (SCA2, SCA38, SCA14, with Friedreich’s ataxia, AOA type 2, MSA-C, FXTAS and SOAO). A two-weeks’ treatment with anodal cerebellar tDCS improves symptoms in patients with ataxia and restores physiological cerebellar brain inhibition pathways. Cerebellar tDCS might represent a promising future therapeutic and rehabilitative approach in patients with neurodegenerative ataxia.
Tuesday, November 29, 2016
Subscribe to:
Posts (Atom)